Clinical Trials Browser

Phase NA × Recruiting × exemestane × Clear all

NCT05890287 2023-06-06

A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy

Phase NA Recruiting

HR Positive HER2 Negative Advanced Breast Cancer